| CGNEX | RGNEX | CGNEX / RGNEX | |
| Total Expense Ratio | 0.93 | 0.67 | 139% |
| Annual Report Gross Expense Ratio | 0.93 | 0.67 | 139% |
| Fund Existence | 14 years | 14 years | - |
| Gain YTD | 14.246 | 14.511 | 98% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 250 | 250 | 100% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 21.7B | 21.7B | 100% |
| Annual Yield % from dividends | 1.34 | 1.56 | 86% |
| Returns for 1 year | 10.83 | 11.12 | 97% |
| Returns for 3 years | 42.23 | 42.34 | 100% |
| Returns for 5 years | 37.33 | 36.21 | 103% |
| Returns for 10 years | 87.87 | 72.23 | 122% |
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| TEMX | 29.20 | 0.11 | +0.39% |
| Touchstone Sands Cap EM ex-China Gr ETF | |||
| FMKT | 21.95 | 0.02 | +0.11% |
| The Free Markets ETF | |||
| AHYB | 46.44 | 0.04 | +0.09% |
| American Century® Select High Yield ETF | |||
| SUSB | 25.22 | N/A | N/A |
| iShares ESG 1-5 Year USD Corp Bd ETF | |||
| PBE | 77.90 | -0.22 | -0.28% |
| Invesco Biotechnology & Genome ETF | |||